Drug and Device Product Liability Litigation Strategy - Herrmann, Mark; Alden, David B; Drake, Geoffrey M
292,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
payback
146 °P sammeln
  • Gebundenes Buch

Each year sees thousands of lawsuits filed to seek recovery from manufacturers of pharmaceuticals and medical devices. In this high-stakes, rapidly-evolving field of practice, this book provides valuable assistance to lawyers through strategic guidance, practice pointers, and discussion on key shifts in the legal landscape since the first edition.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Each year sees thousands of lawsuits filed to seek recovery from manufacturers of pharmaceuticals and medical devices. In this high-stakes, rapidly-evolving field of practice, this book provides valuable assistance to lawyers through strategic guidance, practice pointers, and discussion on key shifts in the legal landscape since the first edition.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Mark Herrmann is Vice President and Chief Counsel - Litigation at Aon Corporation, which is the world's leading insurance and reinsurance broker. Before joining Aon, he was a partner at Jones Day, where his practice focused on the defense of class action and mass tort litigation, including pharmaceutical and medical device cases. He clerked for Judge Dorothy W. Nelson of the United States Court of Appeals for the Ninth Circuit and graduated from The University of Michigan Law School (J.D. 1983) and Princeton University (A.B. 1979). David B. Alden is a partner in Jones Day's Cleveland office, where his practice focuses on products liability litigation, including pharmaceutical and medical device cases; securities and accounting fraud litigation; and issues relating to the attorney-client privilege and work product protection. Geoffrey M. Drake is a partner in King and Spalding's Tort Litigation and Environmental Group, where he represents companies in high-exposure product liability, personal injury, toxic tort, commercial and whistleblower litigation, as well as internal and external government investigations. He is also a member of the Next Generation Advisory Board for Emory University's Institute for Complex Litigation and Mass Claims.